Final Agenda Announced for CHI’s FAST: Functional Analysis & Screening Technologies Congress
Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies.
Needham, MA, July 27, 2013 --(PR.com)-- Taking place October 28-30, 2013 in Cambridge, MA, Cambridge Healthtech Institute’s FAST: Functional Analysis & Screening Technologies Congress will deliver both time-tested and novel strategies for refining first-stage drug discovery methods with assay design on three-dimensional tissue models and phenotypic models. The premier event will bring together leading drug research and development teams for the three days of practical discussion, solutions-driven presentations and real-world case studies.
The final agenda is now available and includes dedicated conferences on Engineering Functional 3-D Tissue Models, Screening and Functional Analysis of 3-D Models, Phenotypic Drug Discovery, and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Additionally, four dinner short courses are available on the topics of Scaffolds, Automating 3-D Cell Culture, High-Content Phenotypic Screening, and Meeting the Need for Physiologically-Relevant Assays.
Among the full lineup of notable speakers are featured presenters from leading pharmaceutical and academia research teams:
- Karen J.L. Burg, Ph.D., Hunter Endowed Chair and Professor of Bioengineering, Clemson University
- D. Lansing Taylor, Ph.D., Director, University of Pittsburgh Drug Discovery Institute
- Steve Ludbrook, Ph.D., Section Head, Screening and Compound Profiling, GlaxoSmithKline
- Aaron Morris, Ph.D., Lab Head, Cancer Biology, Sanofi Oncology
To view the final agenda, including a full speaker list, program abstracts and registration details, visit http://www.fastcongress.com. Early registration discounts apply.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.
The final agenda is now available and includes dedicated conferences on Engineering Functional 3-D Tissue Models, Screening and Functional Analysis of 3-D Models, Phenotypic Drug Discovery, and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Additionally, four dinner short courses are available on the topics of Scaffolds, Automating 3-D Cell Culture, High-Content Phenotypic Screening, and Meeting the Need for Physiologically-Relevant Assays.
Among the full lineup of notable speakers are featured presenters from leading pharmaceutical and academia research teams:
- Karen J.L. Burg, Ph.D., Hunter Endowed Chair and Professor of Bioengineering, Clemson University
- D. Lansing Taylor, Ph.D., Director, University of Pittsburgh Drug Discovery Institute
- Steve Ludbrook, Ph.D., Section Head, Screening and Compound Profiling, GlaxoSmithKline
- Aaron Morris, Ph.D., Lab Head, Cancer Biology, Sanofi Oncology
To view the final agenda, including a full speaker list, program abstracts and registration details, visit http://www.fastcongress.com. Early registration discounts apply.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.
Contact
Cambridge Healthtech Institute
James Prudhomme
781-972-5400
www.chicorporate.com
James Prudhomme
781-972-5400
www.chicorporate.com
Contact
Categories